PCI Pharma Services Announces European Clinical Site Expansion to Support Growth
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) has announced the expansion of its Bridgend UK Clinical site. Ground works and Construction began on September 12, 2016 of a new Clinical services facility at Central Park on Bridgend Industrial Estate, one of four PCI European-based locations supporting investigational study materials.
The facility expansion at the Bridgend location will provide 37,500 sq ft of additional space in support of the secondary packaging and logistical services provided at the Clinical Services Center of Excellence. PCI features highly specialized capability and expertise in supporting temperature-sensitive therapies, including Cold Chain and Ultra Cold Chain, at temperatures ranging from Controlled Ambient 15-25°C, 2-8°C, down to -20°C, -30°C -40°C, -60°C to -90°C and including liquid nitrogen vapour phase storage below -150°C for Advanced Therapeutic Medicinal Products (ATMPs), as well as bespoke refrigerated and frozen temperatures according to client needs.
Source: Packaging Europe